Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study
Journal
Dermatology and therapy
Journal Volume
12
Journal Issue
2
Pages
511
Date Issued
2022-02
Author(s)
Foley, Peter
Rodins, Karl
Hamadah, Issam Ribhi
Ammoury, Alfred
Dayem, Hussein Abdel
Abdallah, Mahmoud
et al.,
Abstract
Secukinumab has demonstrated sustained long-term efficacy with a favourable safety profile in various manifestations of psoriatic disease. We investigated effectiveness and safety of secukinumab, other biologics and conventional systemic therapies in patients with chronic plaque psoriasis in a real-world setting.
Subjects
Biologics; Psoriasis; Real-world; Safety; Secukinumab
SDGs
Publisher
ADIS INT LTD
Type
journal article